These are some of the top stories affecting key drug and biotech stocks that are covered with more in-depth details and analysis this morning at BioHealthInvestor.com: Amgen Inc’s (Nasdaq: AMGN)’s osteoporosis drug…
Amylin Pharmaceuticals, Inc., (NASDAQ: AMLN) has been a battered biotech lately. But shares have just now gotten back above the single-digit threshold and are up more than 80% from recent lows. This…
Alkermes (NASDAQ: ALKS) and Johnson & Johnson Pharmaceutical Research and Developed today submitted paperwork seeking approval of their partnership drug, RISPERDAL CONSTA, to be allowed for treatment of bipolar disorder chronic relapse.…
Credit Suisse downgraded key power stocks: NRG Energy (NRG), Edison(EIX), and Entergy (ETR) all downgraded to Neutral on valuation afterlarge runs. The top 10 individual analysts calls 24/7 Wall St. is looking…
